Potential influence of international harmonization of pharmaceutical regulations on biopharmaceutical development

1998, Quality of Biotechnological Products: stability Testing of Biotechnological/Biological Products, Fed Reg, 61, 36466 1996, Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of rDNA Derived Protein Products, Fed Reg, 61, 7006 Chiu, 1994, Genetic stability of rDNA production systems, a case report, Dev Biol Standard, 83, 93 1991, Committee on Process Development and Manufacturing, Pharmaceutical Manufacturers Association: Assessment of genetic stability of biotechnology products, 4, 22 Garnick, 1994, Report on the genetic stability symposium West Coast chapter, parenteral drug association, Dev Biol Standard, 83, 177 1985 1992 Galibert, 1990, Stability of a gene recombinant: what does it mean and how to check for it?, Biologicals, 18, 221, 10.1016/1045-1056(90)90010-W Galibert, 1990, Letter to the editor, Biologicals, 18, 355, 10.1016/1045-1056(90)90042-X Burstyn, 1993, Genetic stability and recombinant product consistency, Biologicals, 21, 147, 10.1006/biol.1993.1064 Burstyn, 1991, Assessment of genetic stability for biotechnology products, Biopharm, 4, 25 1994 Rosenberger, 1994, Translational errors during recombinant protein synthesis, Dev Biol Standard, 83, 21 Rohde, 1994, Peptide mapping of recombinant proteins, Dev Biol Standard, 83, 121 Horaud, 1994, Meeting summary, Dev Biol Standard, 83, 187 O'Connor, 1994, New techniques in protein chemistry, Dev Biol Standard, 83, 165 1996, Draft Guideline on Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, Fed Reg, 61, 21882 1982, Possible transfusion-associated acquired immunodeficiency syndrome (AIDS)—California, Morbid Mortal Weekly Rep, 31, 652 1985, Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome, Morbid Mortal Weekly Rep, 34, 1 Horowitz, 1993, Viral safety of solvent-detergent-treated blood products, Dev Biol Standard, 81, 147 Nowak, 1993, Inactivation of HIV, HBV, HCV, HCV related viruses and other viruses in human plasma derivatives by pasteurization, Dev Biol Standard, 81, 169 1991 1991 Burstyn, 1996, Contamination of genetically engineered Chinese hamster ovary cells, Dev Biol Standard, 88, 199 Nettleton, 1980, The association of calf serum with the contamination of BHK21 suspension cells by a parvovirus serologically related to Minute Virus of Mice (MVM), Arch Virol, 64, 359, 10.1007/BF01320621 Garnick, 1996, Experience with viral contamination in cell culture, Dev Biol Standard, 88, 49 Lubiniecki, 1996, Survey of manufacturers and developers of cell culture-derived products for evidence of adventitious contamination, Dev Biol Standard, 88, 195 1997, Quality of Biotechnological Products: Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products 1996 1996, International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use: Preclinical Testing of Biotechnology-Dervied Pharmaceuticals